Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 3.815.752.905.004.89

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 3.81 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20253.81
Mar20245.75
Mar20232.90
Mar20225.00
Mar20214.89

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 3.81
-33.74
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5
2.25
Mar2021 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹620.9 Cr -3.7% -11.6% 32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹375,388.0 Cr -2.2% -8.3% -13.1% Stock Analytics
DIVIS LABORATORIES ₹162,513.0 Cr -1.1% -7.3% 21.6% Stock Analytics
CIPLA ₹126,733.0 Cr -0.7% 1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,292.0 Cr -0.5% -4.2% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,935.0 Cr -0.5% -1.1% -7.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-3.7%

-11.6%

32.5%

SENSEX

-1.8%

-1.6%

-2%


You may also like the below Video Courses